X
20
Fresenius Kabi Oncology Limited Kalyani In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Docetaxel, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2012-293 - Rev 02
This Chemical Type CEP, issued on November 17, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2593 associated with this CEP further emphasizes